Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study

Purpose: Current ocular antiseptic practice for intravitreal injection (IVI) employs 5% povidone–iodine (Betadine®) drops which frequently cause ocular discomfort and prolonged irritation. In an effort to improve comfort while maintaining efficacy, we studied a hypochlorous acid (HOCL 0.01%) spray w...

Full description

Bibliographic Details
Main Authors: Anthony Fam, Paul T Finger, Ankit S Tomar, Gaurav Garg, Kimberly J Chin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=11;spage=2439;epage=2444;aulast=Fam
_version_ 1818341323656134656
author Anthony Fam
Paul T Finger
Ankit S Tomar
Gaurav Garg
Kimberly J Chin
author_facet Anthony Fam
Paul T Finger
Ankit S Tomar
Gaurav Garg
Kimberly J Chin
author_sort Anthony Fam
collection DOAJ
description Purpose: Current ocular antiseptic practice for intravitreal injection (IVI) employs 5% povidone–iodine (Betadine®) drops which frequently cause ocular discomfort and prolonged irritation. In an effort to improve comfort while maintaining efficacy, we studied a hypochlorous acid (HOCL 0.01%) spray washout prior to injection. Methods: Patients had received a minimum of 3 IVIs prepared with Betadine®antisepsis prior to entry in this study. Their subsequent IVIs were prepared with Betadine®followed by HOCL 0.01% washout. Facets of comfort were measured by a Likert-scaled questionnaire to compare their experiences after IVI. Results: Thirty-seven participants were enrolled. Addition of HOCL 0.01% spray after Betadine®reduced the duration of discomfort (P = 0.001) and need for artificial tears postinjection (P = 0.003). It improved their reported quality of life (P = 0.04) and sleep (P = 0.01). There were neither HOCL-related side effects nor endophthalmitis during this study. Conclusion: Topical HOCL 0.01% spray after topical Betadine®antisepsis significantly improved patient comfort following IVIs.
first_indexed 2024-12-13T15:56:58Z
format Article
id doaj.art-b85df0d4f4594702a05e1ed90cc6194d
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-13T15:56:58Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-b85df0d4f4594702a05e1ed90cc6194d2022-12-21T23:39:17ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892020-01-0168112439244410.4103/ijo.IJO_2001_20Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes studyAnthony FamPaul T FingerAnkit S TomarGaurav GargKimberly J ChinPurpose: Current ocular antiseptic practice for intravitreal injection (IVI) employs 5% povidone–iodine (Betadine®) drops which frequently cause ocular discomfort and prolonged irritation. In an effort to improve comfort while maintaining efficacy, we studied a hypochlorous acid (HOCL 0.01%) spray washout prior to injection. Methods: Patients had received a minimum of 3 IVIs prepared with Betadine®antisepsis prior to entry in this study. Their subsequent IVIs were prepared with Betadine®followed by HOCL 0.01% washout. Facets of comfort were measured by a Likert-scaled questionnaire to compare their experiences after IVI. Results: Thirty-seven participants were enrolled. Addition of HOCL 0.01% spray after Betadine®reduced the duration of discomfort (P = 0.001) and need for artificial tears postinjection (P = 0.003). It improved their reported quality of life (P = 0.04) and sleep (P = 0.01). There were neither HOCL-related side effects nor endophthalmitis during this study. Conclusion: Topical HOCL 0.01% spray after topical Betadine®antisepsis significantly improved patient comfort following IVIs.http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=11;spage=2439;epage=2444;aulast=Famantisepsisbetadine®comforthoclhypochlorous acidintravitrealproprophylaxisquality of life
spellingShingle Anthony Fam
Paul T Finger
Ankit S Tomar
Gaurav Garg
Kimberly J Chin
Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
Indian Journal of Ophthalmology
antisepsis
betadine®
comfort
hocl
hypochlorous acid
intravitreal
pro
prophylaxis
quality of life
title Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
title_full Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
title_fullStr Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
title_full_unstemmed Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
title_short Hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection: A patient reported outcomes study
title_sort hypochlorous acid antiseptic washout improves patient comfort after intravitreal injection a patient reported outcomes study
topic antisepsis
betadine®
comfort
hocl
hypochlorous acid
intravitreal
pro
prophylaxis
quality of life
url http://www.ijo.in/article.asp?issn=0301-4738;year=2020;volume=68;issue=11;spage=2439;epage=2444;aulast=Fam
work_keys_str_mv AT anthonyfam hypochlorousacidantisepticwashoutimprovespatientcomfortafterintravitrealinjectionapatientreportedoutcomesstudy
AT paultfinger hypochlorousacidantisepticwashoutimprovespatientcomfortafterintravitrealinjectionapatientreportedoutcomesstudy
AT ankitstomar hypochlorousacidantisepticwashoutimprovespatientcomfortafterintravitrealinjectionapatientreportedoutcomesstudy
AT gauravgarg hypochlorousacidantisepticwashoutimprovespatientcomfortafterintravitrealinjectionapatientreportedoutcomesstudy
AT kimberlyjchin hypochlorousacidantisepticwashoutimprovespatientcomfortafterintravitrealinjectionapatientreportedoutcomesstudy